{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:34:39Z","timestamp":1790037279471,"version":"4.0.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.annder.2017.08.011","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T01:00:20Z","timestamp":1507770020000},"page":"768-775","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cosm\u00e9tiques et m\u00e9dicaments topiques dans l\u2019acn\u00e9\u00a0: o\u00f9 est la fronti\u00e8re\u00a0?"],"prefix":"10.1016","volume":"144","author":[{"given":"F.","family":"Poli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-P.","family":"Claudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Auffret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-T.","family":"Leccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Dr\u00e9no","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2017.08.011_bib0095","first-page":"4","article-title":"Physiopathology of acne vulgaris: recent data, new understanding of the treatments","volume":"14","author":"Pawin","year":"2004","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.annder.2017.08.011_bib0100","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.clindermatol.2004.03.011","article-title":"Comedone formation: etiology, clinical presentation, and treatment","volume":"22","author":"Cunliffe","year":"2004","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.annder.2017.08.011_bib0105","first-page":"273","article-title":"Descriptive epidemiological study of acne on scholar pupils in France during autumn 1996","volume":"127","author":"Daniel","year":"2000","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2017.08.011_bib0110","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jid.2016.11.024","article-title":"The protective effect of Microbiota on S.\u00a0aureus skin colonization depends on the integrity of the epithelial barrier","volume":"137","author":"Burian","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2017.08.011_bib0115","unstructured":"Sant\u00e9 MdASedl. Les produits cosm\u00e9tiques. [Available from: http:\/\/social-sante.gouv.fr\/soins-et-maladies\/medicaments-et-autres-produits-de-sante\/article\/les-produits-cosmetiques2015 (acc\u00e9d\u00e9 le 17\u00a0mars 2016)]."},{"key":"10.1016\/j.annder.2017.08.011_bib0120","unstructured":"ANSM. Surveillance du march\u00e9 des produits cosm\u00e9tiques [Available from: http:\/\/ansm.sante.fr\/Activites\/Surveillance-du-marche-des-produits-cosmetiques\/Reglementation\/(offset)\/32015 (acc\u00e9d\u00e9 le 17\u00a0mars 2016)]."},{"key":"10.1016\/j.annder.2017.08.011_bib0125","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/jdv.12497","article-title":"The science of dermocosmetics and its role in dermatology","volume":"28","author":"Dreno","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2017.08.011_bib0130","unstructured":"Av\u00e8ne. Dermo-cosm\u00e9tique. [Available from: http:\/\/www.eau-thermale-avene.fr\/lexique\/definition-dermo-cosmetique2015 (acc\u00e9d\u00e9 le 17\u00a0mars 2016)]."},{"key":"10.1016\/j.annder.2017.08.011_bib0135","unstructured":"Posay LR. Dermocosm\u00e9tique [Available from: http:\/\/www.laroche-posay.fr\/glossaire-beaute\/d\/dermocosmetique-gl4-w422.aspx2015 (acc\u00e9d\u00e9 le 17\u00a0mars 2016)]."},{"key":"10.1016\/j.annder.2017.08.011_bib0140","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrmicro908","article-title":"Can innate immunity be enhanced to treat microbial infections?","volume":"2","author":"Finlay","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.annder.2017.08.011_bib0145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1468-3083.2010.03685.x","article-title":"Development and evaluation of a Global Acne Severity Scale (GEA Scale) suitable for France and Europe","volume":"25","author":"Dreno","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2017.08.011_bib0150","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/jdv.13776","article-title":"European evidence-based (S3) guideline for the treatment of acne - update 2016 - short version","volume":"30","author":"Nast","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2017.08.011_bib0155","series-title":"Dermatologie. Prise en charge de l\u2019acn\u00e9\u00a0: Soci\u00e9t\u00e9 fran\u00e7aise de dermatologie","author":"Soci\u00e9t\u00e9 fran\u00e7aise de dermatologie","year":"2015"},{"key":"10.1016\/j.annder.2017.08.011_bib0160","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/1346-8138.12520","article-title":"Study of the usefulness of moisturizers on adherence of acne patients treated with adapalene","volume":"41","author":"Hayashi","year":"2014","journal-title":"J Dermatol"},{"key":"10.1016\/j.annder.2017.08.011_bib0165","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/09546634.2015.1079298","article-title":"A double-blinded, randomized, vehicle-controlled study to access skin tolerability and efficacy of an anti-inflammatory moisturizer in treatment of acne with 0.1\u00a0% adapalene gel","volume":"27","author":"Chularojanamontri","year":"2016","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.annder.2017.08.011_bib0170","first-page":"28","article-title":"The role of skin care as an integral component in the management of acne vulgaris: part 2: tolerability and performance of a designated skin care regimen using a foam wash and moisturizer SPF 30\u00a0in patients with acne vulgaris undergoing active treatment","volume":"6","author":"Del Rosso","year":"2013","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.annder.2017.08.011_bib0175","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/jdv.13579","article-title":"The role of topical dermocosmetics in acne vulgaris","volume":"30","author":"Araviiskaia","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2017.08.011_bib0180","first-page":"187","article-title":"A dermocosmetic containing bakuchiol, Ginkgo biloba extract and mannitol improves the efficacy of adapalene in patients with acne vulgaris: result from a controlled randomized trial","volume":"8","author":"Polakova","year":"2015","journal-title":"Clin Cosmet Investig Dermatol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963817303228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963817303228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:05:26Z","timestamp":1758971126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963817303228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0151963817303228"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2017.08.011","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cosm\u00e9tiques et m\u00e9dicaments topiques dans l\u2019acn\u00e9\u00a0: o\u00f9 est la fronti\u00e8re\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2017.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}